Procurement Summary
Country : USA
Summary : Request for Information (Rfi) - Atropine and Pralidoxime Chloride Injection, Single Dose Auto-Injectors
Deadline : 23 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 100060419
Document Ref. No. : SNS-RFI-4152024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Atlanta, GA 30341
Primary Point of Contact : LaMonica Norwood
lamonica.norwood@hhs.gov
USA
Email :lamonica.norwood@hhs.gov
Tender Details
Description
The Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) is seeking information on vendor-s availability to provide acceptable pharmaceuticals of Atropine and Pralidoxime Chloride Injection, single dose auto-injectors that delivers 2.1mg/0.7ml atropine and 600mg/2mg(300mg/ml) pralidoxime chloride. SNS requires that all pharmaceuticals are FDA approved.
Active Contract Opportunity Notice ID SNS-RFI-4152024 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Office ASPR/ORM-SNS
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 15, 2024 08:32 pm EDT
Original Response Date: Apr 23, 2024 02:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 08, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 3650 - CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: Atlanta, GA 30341 USA
Documents
Tender Notice